BRAIN Biotech AG (BNN) — Capital Reinvestment Ratio

Latest as of June 2024: 1.40x

BRAIN Biotech AG (BNN) has a Capital Reinvestment Ratio of 1.40x as of June 2024, meaning it reinvests 1% of its operating cash flow (€516.00K) in capital expenditures (€720.00K). Check BRAIN Biotech AG (BNN) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.40x

Capex / Operating Cash Flow

Operating Cash Flow

€516.00K

EUR

Capital Expenditures

€720.00K

EUR

Data as of

Jun 2024

Most recent filing

Annual Capital Reinvestment Ratio for BRAIN Biotech AG (None–None)

Year-by-year Capital Reinvestment Ratio for BRAIN Biotech AG from None to None. See free cash flow generation of BRAIN Biotech AG to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow